Research Library

This report reviews the key concepts and themes that emerged from the conference “Divided Societies, Volatile States: The Politics of Identity Post-Arab Spring,” hosted by the Baker Institute Center for the Middle East on March 10, 2015.

As the implementation of Mexico’s historic energy reform gets underway, the debate has tended to overlook a key question at the intersection of technology and the new legislation: How can Mexico create an institutional framework supported by policies, laws and organizations to facilitate technology transfers and foster local innovation? Simply put, how will international oil companies transfer technology to Mexican companies and research facilities?

Peter Hotez, fellow in disease and poverty, testified about the continuing threat of neglected tropical diseases before the U.S. House Committee on Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights and International Organizations.

This paper investigates how new potential and proposed regulations will influence the natural gas market in the United States in the coming decades, using the Rice World Gas Trade Model (RWGTM) to examine scenarios in which domestic natural gas development is stressed in a variety of ways. It considers a range of possible policy actions from the federal to the local level.

Drug policy has experienced an interesting shift recently. Along with legalization of medical and recreational marijuana, many states are also reducing penalties for nonviolent drug offenses and placing greater focus on treatment for drug users. The emphasis on treatment and rehabilitation for drug users is the result of many factors, including recognition that the drug war has not reduced drug use, a desire to reduce the prison population and save money, and a surge in the rate of overdoses from opioid and heroin use. What remains to be seen is whether the current popularity of drug treatment will become a more permanent feature of drug policy. In this Baker Institute Viewpoints series, five experts on drug policy examine the question, “Is the current emphasis on treatment in drug policy a short-term trend or is it here to stay?”

Peter Hotez discusses his work on neglected tropical diseases and the future direction of disease elimination and science diplomacy. Published in the journal Molecular Medicine, December 2014.